Ticker Short Interest

BIAF Short Interest Intelligence

bioAffinity Technologies, Inc. positioning pressure, squeeze risk, bearish conviction, crowding, days to cover, and price-positioning divergence.

Latest settlement 30 Jun 2026 Bearish Conviction

Bearish Conviction

Shorts Winning

BIAF is classified as Bearish Conviction. Latest reported short interest is 816.6K shares; short interest changed +124.8%, price moved -43.9% since the previous report, short interest is in the 100th percentile, and days to cover is in the 43th percentile. Trend context is weak.

Setup Score87/100Bearish Conviction
Reported Short Interest816.6K+124.8% vs prior report
Days To Cover1.0042.86 percentile
Price Reaction-43.9%since previous short report
Squeeze Pressure59crowding, trend, and pressure
Bearish Conviction87shorts adding into weakness

Reported Short Interest

2026-03-31 to 2026-06-30

Days To Cover

liquidity pressure

Short Interest Change

report-to-report

Price Context

2026-03-20 to 2026-06-26

Squeeze Radar

59

Elevated short interest becomes most interesting when price strength forces shorts to defend or cover.

Bearish Conviction

87

Rising short interest alongside weak trend can mean the bearish trade is being reinforced, not trapped.

Crowding

74

Latest short interest is 816.6K shares and days to cover is 1.00.

Divergence

0

Short interest rose while price fell. The bearish trade is currently being confirmed by price.

Report History

BIAF Short Interest Ledger

Most recent first
SettlementShort interestPreviousChangeDays coverAverage volume
30 Jun 2026 816644 363268 124.8% 1.00 849109
15 Jun 2026 363268 445095 -18.4% 1.72 211569
29 May 2026 445095 494011 -9.9% 3.02 147219
15 May 2026 494011 676404 -27.0% 1.89 261654
30 Apr 2026 676404 515756 31.2% 1.44 471327
15 Apr 2026 515756 542083 -4.9% 1.00 1719268
31 Mar 2026 542083 535630 1.2% 1.00 20718286

Short interest is delayed, reported on a periodic schedule, and may be revised. The dashboard is research context only and does not prove real-time short activity.